Lombard Gerhard purchased $22K of CCAP

Lombard Gerhard (Chief Financial Officer) purchased 2,000 shares of Crescent Capital BDC, Inc. (CCAP) at $10.91 on 2026-08-19.

Original reporting
SEC EDGAR · Lombard Gerhard
Published Aug 20, 2026, 8:36 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Aug 20, 2026, 9:08 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$CCAP
Neutral
high confidence
Mentioned
$CCAP
Relevance
4/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$CCAPNeutralLow
01

Why it matters

The CFO's purchase is modest and does not suggest a material change in outlook for Crescent Capital BDC.

02

Market read

Low relevance; the filing provides a minor data point for insiders tracking.

03

What to watch

Potential upcoming corporate actions not disclosed; otherwise no hidden catalysts.

Relevance 4/10Novelty 4/10Timing: post-market filing

Background

Form 4 filings disclose insider transactions; traders monitor them for signals of insider confidence.

Company-level read

Ticker impact

$CCAPNeutralHigh confidence
Context

CFO Lombard Gerhard bought 2,000 shares of Crescent Capital BDC, Inc. for $21,820, increasing his stake to 40,509 shares.

Expected impact

No material impact expected.

Evidence & confidence

Purchase size is small relative to market cap and typical trading volume.

Market effects

None

None

None

Counterpoint

Even small insider buys can signal confidence, but the amount is too trivial here.

Key entities

  • Crescent Capital BDC, Inc.

    Business development company listed on NYSE.

  • Lombard Gerhard

    Chief Financial Officer of Crescent Capital BDC.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$CCAPHigh

Crescent Capital Q3 2026 slides: earnings beat, $50M buyback unveiled

Crescent Capital BDC (CCAP) reported Q3 2026 earnings of $0.37 per share, beating estimates. The company announced a $50M share buyback and a joint venture to reduce leverage. Shares rose 6.82% in after-hours trading to $9.87, still below NAV. Portfolio assets reached $1.6B, with 91% in senior secured positions. Net investment income declined year-over-year, and NAV per share fell 8%.

$CCAPMed

Crescent Capital BDC, Inc. Reports Third Quarter 2026 Earnings Results

Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Crescent Capital BDC, Inc. Reports Third Quarter 2026 Earnings Results; Declares a Fourth Quarter Base Dividend of $0.34 Per Share and Announces a $50 Million Share Repurchase Program LOS ANGELES, November 9, 2026 — Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ

$CCAPMed

Crescent Capital BDC, Inc. Reports Second Quarter 2026 Earnings Results

Crescent Capital BDC, Inc. (CCAP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Crescent Capital BDC, Inc. Reports Second Quarter 2026 Earnings Results; Declares a Third Quarter Base Dividend of $0.34 Per Share LOS ANGELES, August 10, 2026 — Crescent Capital BDC, Inc. (“Crescent BDC” or “Company”) (NASDAQ: CCAP) today reported net investment income of $0.36